Modulation of G6PD-mediated Vitamin C Sensitivity in Small Cell Lung Cancer by the AKT/NRF2 axis
Journal of Biological Chemistry · 2026-11 · 113734
DOI: 10.1016/j.jbc.2026.113734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-11. Verfasst von Xinhuang Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, …. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Small cell lung cancer (SCLC) remains a highly lethal malignancy with limited therapeutic advances. Although high-dose vitamin C (Vc) exhibits anti-tumor activity in various cancers, its therapeutic potential and underlying resistance mechanisms in SCLC remain poorly understood. Here, we identified heterogeneous responses to Vc among SCLC cell lines and found that Vc-resistant cells acquire enhanced antioxidant capacity to tolerate Vc-induced oxidative stress. Through transcriptomic, multi-omics, and functional analyses, we identified glucose-6-phosphate dehydrogenase (G6PD) as a critical determinant of Vc resistance. Mechanistically, Vc activates the p-AKT/p-GSK3β/NRF2 signaling axis in resistant cells, leading to NRF2-dependent transcriptional upregulation of G6PD and activation of antioxidant adaptation programs. Integrated analyses of transcriptomic, proteomic, single-cell, and spatial transcriptomic datasets further supported the involvement of the NRF2-G6PD axis in oxidative stress adaptation in SCLC. Importantly, pharmacological inhibition of G6PD with RRx-001 restored Vc sensitivity and synergistically suppressed SCLC growth in vitro and in vivo. Collectively, our findings reveal a previously unrecognized mechanism underlying Vc resistance in SCLC and demonstrate that co-targeting G6PD provides a potential strategy to enhance the therapeutic efficacy of Vc.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China.
- High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui, China; Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, Sir Y.K. Pao C…
- High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui, China; Anyang Hospital of Traditional Chinese Medicine, Anyang, Henan, China.
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China; High Magnetic Field Laboratory, Chinese Academy of Sc…
- Shenzhen University Medical School, Shenzhen, China.
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China. Electronic address: cgzhwaxx@mail.ustc.edu.cn.
Zitieren
APA
Yao, X., Lyu, Y., Zhang, Z., Li, G., Guo, R., Li, H., Xiang, L., Cao, G., & Lin, W. (2026). Modulation of G6PD-mediated Vitamin C Sensitivity in Small Cell Lung Cancer by the AKT/NRF2 axis. Journal of Biological Chemistry, 113734. https://doi.org/10.1016/j.jbc.2026.113734
Vancouver
Yao X, Lyu Y, Zhang Z, Li G, Guo R, Li H, et al. Modulation of G6PD-mediated Vitamin C Sensitivity in Small Cell Lung Cancer by the AKT/NRF2 axis. Journal of Biological Chemistry. 2026:113734. doi:10.1016/j.jbc.2026.113734
BibTeX
@article{Yao2026,
author = {Yao, Xinhuang and Lyu, Yang and Zhang, Zonghui and Li, Gongfeng and Guo, Rui and Li, Honglin and Xiang, Li and Cao, Guozhen and Lin, Wenchu},
title = {Modulation of G6PD-mediated Vitamin C Sensitivity in Small Cell Lung Cancer by the AKT/NRF2 axis},
journal = {Journal of Biological Chemistry},
year = {2026},
pages = {113734},
doi = {10.1016/j.jbc.2026.113734}
}
EUVIMED